All In MedTech

FDA Clearance Tracker · K830934

QUANTIMETRIX BROMERESOL PURPLE ALBUMIN

A 510(k) clearance means FDA found the device substantially equivalent to one already on the market. It is not an approval, and it is not a finding that the device works better than others.

Last checked: Nov 20, 2026Latest source record: Apr 18, 1983 (this decision)Source: openFDAMethods & limitations

510(k)First of its product code

Decided

Apr 18, 1983

Substantially Equivalent

Time to decision

26 days

Received Mar 23, 1983. Calendar days, including time FDA spent waiting on the applicant.

Pathway

510(k)

Traditional

Device class

Class II

The decision

FDA number
K830934
Device name
QUANTIMETRIX BROMERESOL PURPLE ALBUMIN
Applicant location
Mchenry, IL
Received
Mar 23, 1983
Decided
Apr 18, 1983
Decision
Substantially Equivalent
Submission type
Traditional

Device type

Device class
Class II
Regulation
21 CFR 862.1035

Every decision under product code CJW

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • This is the earliest decision in FDA's data under product code CJW (Bromcresol Purple Dye-Binding, Albumin).
  • It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.

Source documents

The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.

Other decisions for Quantimetrix Corp.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.